Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Quarterly results

MusclePharm Corp (MSLP) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/19/2023 8-K Quarterly results
03/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/11/2023 8-K Quarterly results
01/10/2023 8-K Changes in Registrant's Certifying Accountant
Docs: "Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549"
01/09/2023 8-K Quarterly results
12/21/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/29/2022 8-K Quarterly results
08/23/2022 8-K Quarterly results
08/22/2022 8-K Quarterly results
08/16/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
07/28/2022 8-K Quarterly results
07/28/2022 4 Rizvi Sabina (President & CFO) has filed a Form 4 on MusclePharm Corp
Txns: Granted 1,811,000 options to buy @ $0.4, valued at $724.4k
07/28/2022 3 Rizvi Sabina (President & CFO) has filed a Form 3 on MusclePharm Corp
07/12/2022 8-K Quarterly results
06/22/2022 3 Chin Eric (Chief Accounting Officer) has filed a Form 3 on MusclePharm Corp
06/22/2022 8-K Quarterly results
06/16/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/14/2022 8-K Quarterly results
06/09/2022 8-K Quarterly results
05/17/2022 8-K Quarterly results
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/05/2022 8-K Quarterly results
05/04/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
04/28/2022 8-K Quarterly results
Docs: "MusclePharm Corporation Consolidated Statements of Operations"
04/15/2022 10-K Annual Report for the period ended December 31, 2021
04/01/2022 SC 13D/A White Winston Select Asset Fund Series Fund MP-18, LLC reports a 9% stake in MusclePharm Corporation
03/31/2022 4 White Winston Select Asset Fund Series Fund MP-18, LLC (10% Owner) has filed a Form 4 on MusclePharm Corp
Txns: Sold 626,826 shares @ $0
03/31/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/11/2022 8-K Quarterly results
02/22/2022 SC 13D/A White Winston Select Asset Fund Series Fund MP-18, LLC reports a 10.9% stake in MusclePharm Corporation
12/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/17/2021 10-Q Quarterly Report for the period ended September 30, 2021
11/15/2021 8-K Quarterly results
Docs: "Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue, net $ 11,971 $ 16,085 $ 40,000 $ 49,309 Cost of revenue 11,942 11,073 34,102 34,504 Gross profit 29 5,012 5,898 14,805 Operating expenses: General and administration 2,453 3,586 7,609 11,001 Selling and promotion 1,012 623 3,195 2,100 Impairment of intangible assets - 167 - 167 Total operating expenses 3,465 4,376 10,804 13,268 Income from operations 636 1,537 Other income: Loss on settlement obligation"
11/02/2021 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "John Mills, Managing Partner"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy